Danaher Corporation $DHR Stake Boosted by Capital Advisors Inc. OK

Capital Advisors Inc. OK increased its stake in Danaher Corporation (NYSE:DHR) by 24.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 217,130 shares of the conglomerate’s stock after purchasing an additional 42,808 shares during the period. Capital Advisors Inc. OK’s holdings in Danaher were worth $43,048,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in DHR. WFA of San Diego LLC bought a new stake in Danaher in the second quarter valued at $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Danaher in the 2nd quarter worth about $27,000. TruNorth Capital Management LLC acquired a new stake in shares of Danaher in the 3rd quarter worth about $28,000. Red Tortoise LLC lifted its position in Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares during the last quarter. Finally, Tripletail Wealth Management LLC acquired a new position in Danaher during the 3rd quarter valued at about $31,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

Shares of Danaher stock opened at $230.42 on Friday. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. The stock has a market cap of $162.76 billion, a PE ratio of 47.51, a price-to-earnings-growth ratio of 4.10 and a beta of 0.89. The company’s 50-day moving average price is $223.80 and its two-hundred day moving average price is $209.19.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. During the same quarter last year, the firm posted $1.71 EPS. The business’s revenue for the quarter was up 4.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a $0.32 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio is currently 26.39%.

Analysts Set New Price Targets

DHR has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. lifted their price target on Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Wells Fargo & Company raised their target price on Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a research report on Monday, December 15th. KeyCorp reiterated an “overweight” rating on shares of Danaher in a research report on Thursday, December 18th. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Finally, Barclays lifted their price objective on shares of Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Twenty-one equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $249.29.

Insider Activity

In other news, Director Teri List sold 3,298 shares of the stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the sale, the director owned 20,762 shares in the company, valued at approximately $4,702,593. This represents a 13.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Georgeann Couchara sold 5,174 shares of the firm’s stock in a transaction on Monday, November 10th. The stock was sold at an average price of $210.42, for a total value of $1,088,713.08. Following the completion of the sale, the senior vice president directly owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. This trade represents a 66.34% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 30,248 shares of company stock worth $6,609,663. Insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.